NYU Langone Hospitals — New York, New York

NYU Langone Hospitals is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

NYU Langone Hospitals has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Endometrial Neoplasms.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU Langone Hospitals?

NYU Langone Hospitals has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU Langone Hospitals conducted?

NYU Langone Hospitals has 1 clinical trials on record, with 1 currently active. Their work covers Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Endometrial Neoplasms.

Is NYU Langone Hospitals accredited by Crixeo Health?

NYU Langone Hospitals has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NYU Langone Hospitals?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.